Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples